All posts by: Michael Zand

About Michael Zand

Cocoa CRISPR: Gene editing shows promise for improving the ‘chocolate tree’ – Penn State News

Continue reading

2018-05-09 NEWS

Penn State News

Cocoa CRISPR: Gene editing shows promise for improving the ‘chocolate tree’
Penn State News
UNIVERSITY PARK, Pa. — Use of the powerful gene-editing tool CRISPR-Cas9 could help to breed cacao trees that exhibit desirable traits such as enhanced resistance to diseases, according to Penn State plant scientists. The cacao tree, which grows in

Continue reading

2018-05-09 NEWS

Vail’s first patrol dog Henry undergoes stem cell therapy in Gypsum
Vail Daily News
On Monday, May 7, Henry added to his legacy, becoming the third dog to receive stem cell therapy from Gypsum Animal Hospital. “It is an extremely safe, effective, natural, FDA-approved therapy,” said Stephen Sheldon, DVM, of Gypsum Animal Hospital

Continue reading

2018-05-09 NEWS

What’s next for CART cell therapy at Penn
Philadelphia Business Journal
Last week, Novartis received its second approval for Kymriah, a CART cell therapy developed by researchers at Penn Medicine and Children’s Hospital of Philadelphia. The therapy, which involves bioengineering a patient’s own cells to boost their

and more »

Continue reading

2018-05-09 NEWS

Crowdfunding Exaggerates Efficacy of Unproven Stem Cell Tx
Monthly Prescribing Reference
HealthDay News — Crowdfunding campaigns for unproven stem cell-based interventions tend to exaggerate the efficacy and underemphasize the risks, according to a research letter published in the May 8 issue of the Journal of the American Medical
Study: Crowdfunding campaigns for stem cell treatments ‘potentially misleading’Becker’s Hospital Review

all 6 news articles »

Continue reading

2018-05-09 NEWS

The Daily Dot

Secretive startup will use gene therapy to reverse aging in dogs—and humans are next
The Daily Dot
Advances in gene therapy are bringing us closer to immortality, and now one of the world’s most influential scientists is on the job. Renowned geneticist George Church, who pioneered the use of CRISPR to edit the genes of human cells, wants to reverse